Story Navigation
-
DiscoveryCOVID-19Local ImpactWorking at NovartisClinical TrialsDrug DevelopmentJul 14, 2021Helping clinical trial patients during a lockdown
Yan Zhao talks about how her team in China responded to an emerging public health crisis.
Discovery -
Access to HealthcareAccess to HealthcareCancerCOVID-19OncologyWorking at NovartisClinical ResearchJul 21, 2021Cancer didn’t stop for COVID-19
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
Access to Healthcare -
Access to HealthcareCOVID-19Infectious DiseasesInnovationWorking at NovartisJul 30, 2021Streamlining systems to respond to COVID-19
Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.
Access to Healthcare -
DiscoveryCOVID-19Disease EradicationInfectious DiseasesWorking at NovartisClinical ResearchClinical TrialsJul 15, 2021Moving from speculation to science during a pandemic
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
Discovery -
DiscoveryCOVID-19Disease EradicationInfectious DiseasesWorking at NovartisScientific ResearchJul 15, 2021It takes an R&D village to fight a pandemic
Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Discovery -
From Our LabsCOVID-19Disease EradicationInnovationScientific ResearchJul 20, 2021A visual tour of scientific strategies for combating coronavirus
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
From Our Labs -
People and CultureCOVID-19DigitalClinical ResearchClinical TrialsClinical ScienceDrug DevelopmentAug 10, 2021Going the extra mile to keep clinical trials on track during the COVID-19 pandemic
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
People and Culture -
DiscoveryBiomedical ResearchCOVID-19Data ScienceDiseasesInfectious DiseasesClinical TrialsBiomedical ScienceJul 14, 2021COVID-19: Answering your top questions
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Discovery -
DiscoveryDrug DesignInnovationNovartis Institutes for BioMedical ResearchScientific ResearchSep 27, 2021Visualizing molecular glues
Molecular glues are a new type of medicine inspired by nature’s matchmakers.
Discovery -
Patient PerspectivesDisease AwarenessDiseasesHeart FailurePatient VoicesDrug DevelopmentAug 6, 2021Caring for someone with heart failure
Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.
Patient Perspectives -
Data ScienceDigitalEmerging TechnologyFuture of HealthcareInnovationJul 14, 2021The data42 program shows Novartis’ intent to go big on data and digital
Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.
-
DiscoveryData ScienceDigitalEmerging TechnologyFuture of HealthcareInnovationJul 15, 2021Meet Achim, leading the data42 program
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 30
- › Next page